Biolinq Secures $58M to Advance Continuous Glucose Monitoring Patch
Biolinq, a provider of precision wearable biosensors for metabolic health secures $58M led by Alpha Wave Ventures.
Global Health Investment Corporation Biolinq Secures Advance Continuous Glucose Monitoring Should Know Alpha Wave Pegasus Tech Ventures
Source: hitconsultant.net